Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

The bacterium Clostridioides difficile is named “difficult” for a reason. Originally it was hard to grow in the lab, and now ...

Clostridium difficile infection (CDI) is considered to be the ... Although metronidazole and vancomycin are and have been the mainstay treatment options for CDI, there are some unmet medical ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Researchers have a new battle tactic to fight drug-resistant bacterial infections. Their strategy involves using collections ...

Researchers have a new battle tactic to fight drug-resistant bacterial infections. Their strategy involves using collections ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

Researchers have long observed that a common family of environmental bacteria, Comamonadacae, grow on plastics littered ...

Identifying infection, treating it appropriately, and reviewing efficacy of the treatment is a skill that all clinical ... as disrupting the ecosystem of the gut can lead to Clostridium difficile ...